The University of Rhode Island Doctor of Pharmacy program is accredited by the Accreditation Council for Pharmacy Education.
News and Events
Scientists who once worked together for the global pharmaceutical company Pfizer are now collaborating with URI’s George & Anne Ryan Institute for Neuroscience. The group, which is calling itself MindImmune, is working to build a company they hope will find treatment for diseases of the brain—Alzheimer’s, Parkinson’s and other neuro-degenerative disorders.
College of Pharmacy faculty and students headed to the Rhode Island State House on April 5, for the 13th Annual Face of Pharmacy event, where they joined forces with members of organizations including Rhode Island Pharmacists Association and Rhode Island Society of Health-System Pharmacists to “put a face” on the issues and legislation that affect pharmacy.
The University of Rhode Island is putting in place a sweeping reorganization of its health programs to maximize cross-disciplinary teaching, research, and outreach and to place the University in a position of strength as health care undergoes rapid change in the United States. URI has established the Academic Health Collaborative to spur cooperation and innovation in the areas of research, inter-professional education, population health, health promotion and recognition and elimination of health disparities.
Pharmacy, nursing, and physical therapy students traveled to Indonesia to participate in an interdisciplinary exploration of global health issues and the social determinants of health there during the University’s January term.
Pomegranates and other “superfoods” are known to have positive effects on the brain—improving functions such as memory and cognition. Now Associate Professor Navindra Seeram and a team of researchers have discovered it may not be the superfoods—rather the way these foodstuffs interact with the body’s microflora during gut microbial metabolism that could lead to breakthroughs in protecting against Alzheimer’s.
Big Data is essential in research and education at URI today. At the College of Pharmacy, Professor Stephen Kogut is using big data from private health insurers and the state’s Medicaid systems to analyze diseases in populations, cost, medication use and hospitalizations. For Rhode Island Medicaid, Kogut and his team analyzed more than 2 million pharmacy dispensing records to try ascertain medication patterns for those with depression to see who might be continuing treatment as recommended.
Political science isn’t the field that comes to mind when considering how to address vaccine hesitancy in adult minorities. For Professor Kerry LaPlante, however, the connection is clear. She is currently at work with URI Political Science Professor and Chair Brian Krueger and Associate Professor Marc Hutchison on a $606,173 research grant to develop science-based messaging to improve pneumococcal vaccination rates in black and Hispanic/Latino populations.
Retired Army Gen. Paul Casinelli vividly remembers taking trips to his father’s drugstore in Cranston as a child. Like his father, Gen. Casinelli attended the University of Rhode Island and graduated in 1976 with a bachelor of science degree in pharmacy.
East and West have always converged in the Bioactive Botanical Research Lab of Pharmacy Professor Navindra Seeram. But a new gift with roots in Traditional Chinese Medicine has brought these culturally different approaches to treating disease and pain even closer.
Xinyuan Chen, assistant professor of biomedical and pharmaceutical sciences, is developing a nicotine vaccine and accompanying drug delivery system that he believes could lead to one of the most effective methods of combating cigarette smoking and other tobacco use. He joined the College of Pharmacy after seven years at Massachusetts General Hospital in Boston, bringing with him a $1.08 million career development grant from the National Institute of Drug Abuse and a $432,000 grant from the National Institute of Allergy and Infectious Disease.
Copyright © 2016 University of Rhode Island.